Chemoimmunotherapy Combined With Autologous NK Cell Therapy for Pediatric Patients With Refractory and Relapsed High-Risk Neuroblastoma and Ganglioneuroblastoma
Abroad (travel likely)RecruitingPHASE3
Conditions
Neuroblastoma (NB) · Ganglioneuroblastoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
National medical research center of pediatric haematology, oncology and immulogy named after Dmytriy Rogachyov, Moscow, 117198, Moscow, Russia
Study leads
Tatyana V Shamanskaya, MD, PHD
Study Director
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology